tropicamide has been researched along with Dementia in 3 studies
Tropicamide: One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The anticholinergic agent tropicamide causes a significantly greater change in the pupil diameter of patients with Alzheimer's disease (AD) than in that of patients with alcoholic or vascular dementia or in normal controls." | 7.69 | Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia. ( Arai, H; Hasegawa, Y; Higuchi, S; Matsushita, S; Muramatsu, T, 1997) |
| "01% tropicamide receptor test allows to discriminate between different dementia types of, as demonstrated in our study." | 3.75 | [The pupillary response test as a method to differentiate various types of dementia]. ( Frottier, P; Grünberger, J; Haushofer, M; Prause, W; Rainer, M; Saletu, B; Stöhr, H, 2009) |
| "The anticholinergic agent tropicamide causes a significantly greater change in the pupil diameter of patients with Alzheimer's disease (AD) than in that of patients with alcoholic or vascular dementia or in normal controls." | 3.69 | Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia. ( Arai, H; Hasegawa, Y; Higuchi, S; Matsushita, S; Muramatsu, T, 1997) |
| "Currently Alzheimer's disease, which affects more than 20 million people worldwide, can only be definitely diagnosed by histological examination of brain tissue obtained at autopsy or biopsy." | 2.67 | A potential noninvasive neurobiological test for Alzheimer's disease. ( Daffner, KR; Dressler, D; Mesulam, M; Potter, H; Ransil, BI; Rentz, D; Scinto, LF; Weintraub, S, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grünberger, J | 1 |
| Prause, W | 1 |
| Frottier, P | 1 |
| Stöhr, H | 1 |
| Saletu, B | 1 |
| Haushofer, M | 1 |
| Rainer, M | 1 |
| Scinto, LF | 1 |
| Daffner, KR | 1 |
| Dressler, D | 1 |
| Ransil, BI | 1 |
| Rentz, D | 1 |
| Weintraub, S | 1 |
| Mesulam, M | 1 |
| Potter, H | 1 |
| Higuchi, S | 1 |
| Matsushita, S | 1 |
| Hasegawa, Y | 1 |
| Muramatsu, T | 1 |
| Arai, H | 1 |
1 trial available for tropicamide and Dementia
| Article | Year |
|---|---|
A potential noninvasive neurobiological test for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Dementia; Female; Humans; Male; Neuropsychological Tests; Pupil; Reproducib | 1994 |
2 other studies available for tropicamide and Dementia
| Article | Year |
|---|---|
[The pupillary response test as a method to differentiate various types of dementia].
Topics: Aged; Alzheimer Disease; Dementia; Dementia, Vascular; Female; Humans; Lewy Body Disease; Male; Musc | 2009 |
Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia.
Topics: Aged; Aging; Alcoholism; Alzheimer Disease; Dementia; Dementia, Vascular; Humans; Middle Aged; Mydri | 1997 |